Reetika Bhardwaj
Associate at ARCH Venture Partners
Greater Chicago Area
Overview
Work Experience
Board Observer
2024 - Current
Senior Associate
2019
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Board Observer
2021
Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
Raised $72,500,000.00 from University of Cambridge Enterprise, Karolinska, Google Ventures, Mubadala Capital Ventures, Angelini Ventures, Invus, EIR Ventures, HealthCap, ARCH Venture Partners and GU Ventures.
Board Observer
2022
Board Observer
2023
Protillion Biosciences specializes in the design and development of protein-based drugs.
Raised $18,000,000.00 from Illumina Ventures and ARCH Venture Partners.
Board Observer
2021
Innovation Fund Associate
2019 - 2020
• Perform due diligence on a Sleep disorder therapeutics and a pediatric insomnia device company; analyzing potential market, reviewing technology, and assessing development milestone • Advised advisory committee to invest $250K per startup from a $20 M seed fund ; the companies were successfully funded • Served in a venture capital associate role in order to equip the Shultz Innovation Fund Advisory Committee to make investment decisions
UChicagoTech launched the Innovation Fund in 2010 to accelerate the commercialization of promising.
Investment Banking Associate (M&A)
2019 - 2019
Credit Suisse Group is a financial services company that advises clients in all aspects of finance.
I-Corp Fellow
2018 - 2019
Business Development Lead for early stage startups in the field of Neuroscience- Alzheimer and Sleep Apnea
Scientific Advisor and Business Development
2015 - 2018
Spectrums unique business approach is working our clients know it, our veteran and newly hired team members.